Program: Clinical relevance of eosinophils in gastrointestinal diseases
Chair: Prof. dr. T. Vanuytsel (KU Leuven, Belgium) and Prof. dr. A. Bredenoord (UMC Amsterdam, The Netherlands)
09:00 – 10:00 | Welcome |
Eosinophils in the esophagus | |
10:00 – 10:25 | Pathophysiology and increasing incidence of EoE Dr. Marijn Warners (St. Antonius Ziekenhuis, The Netherlands) |
10:25 – 10:50 | Medical therapy of EoE Prof. dr. Arjan Bredenoord (UMC Amsterdam, The Netherlands) |
10:50 – 11:15 | Diet and dilatation Prof. dr. Joris Arts (AZ Sint-Lucas, Belgium) |
Coffee break (15 min) | |
Eosinophils in the stomach and small bowel | |
11:30 – 11:55 | Is functional dyspepsia an eosinophilic disease? Dr. Lucas Wauters (KU Leuven, Belgium) |
11:55 – 12:20 | Therapy of functional dyspepsia Dr. Jolien Schol (KU Leuven, Belgium) |
Eosinophilic gastritis and gastroenteritis Prof. dr. Tim Vanuytsel (KU Leuven, Belgium) |
|
12:55 - 13:45 Lunch | |
Eosinophils in the colon | |
13:45 – 14:10 | Eosinophils in IBD: prognostic marker and new therapeutic target? Dr. Joep Grootjans (Amsterdam UMC, The Netherlands) |
14:10 – 14:35 | Diagnosis and therapy of microscopic colitis. Dr. Bram Verstockt (KU Leuven, Belgium) |
14:35 – 15:00 | Pathophysiology of IBS: food, mast cells and eosinophilia Prof. dr. Guy Boeckxstaens (KU Leuven, Belgium) |
15:00 – 15:25 | Therapy of IBS Dr. Daniel Keszthelyi (Maastricht UMC+, The Netherlands) |
15:25 – 15:30 | Closure |
Accreditation has been submitted to the NVMDL and MDEON.
Participation is free of charge.
This event is subject to the Dutch RIVM guidelines concerning COVID-19. This means that the live event can be converted into a Webinar.